Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | MRK | ABBV |
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | Merck & Company | Abbvie Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 82.72 | 811.35 | 143.05 | 98.83 | 171.79 |
| High | 86.53 | 811.35 | 145.47 | 99.68 | 176.80 |
| Low | 81.50 | 766.61 | 142.75 | 97.90 | 170.66 |
| Last | 85.00 | 767.76 | 144.47 | 98.05 | 175.58 |
| Change | -18.44 | +10.22 | +0.89 | -1.47 | +4.06 |
| % Change | -17.83% | +1.35% | +0.62% | -1.48% | +2.37% |
| Volume | 53,762,400 | 9,942,200 | 17,702,700 | 29,289,700 | 18,950,900 |
| 20-Day Average Volume | 7,389,715 | 3,810,880 | 8,983,115 | 14,186,050 | 6,898,985 |
| Previous Close | 103.44 | 757.54 | 143.58 | 99.52 | 171.52 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 106.65 | 789.47 | 149.69 | 101.05 | 176.68 |
| 20-Day Raw Stochastic | 11.28% | 26.07% | 11.97% | 3.17% | 38.28% |
| 20-Day Relative Strength | 24.15% | 40.95% | 33.09% | 40.94% | 45.41% |
| Weighted Alpha | -32.76 | +17.41 | -9.92 | -17.29 | +6.96 |
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 56% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 56% Sell |
| Last Month's Opinion | 100% Sell | 56% Sell | 24% Sell | 100% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.52% since 12/13/24 | -2.71% since 12/13/24 | -1.47% since 12/13/24 | -3.87% since 12/13/24 | +1.27% since 12/13/24 |
| Low | 81.50 on 12/20/24 | 752.40 on 12/19/24 | 142.75 on 12/20/24 | 97.82 on 12/19/24 | 170.21 on 12/17/24 |
| High | 109.88 on 12/16/24 | 811.35 on 12/20/24 | 147.25 on 12/16/24 | 102.28 on 12/16/24 | 176.80 on 12/20/24 |
| 1-Month | |||||
| %Chg | -19.26% since 11/20/24 | +1.90% since 11/20/24 | -5.64% since 11/20/24 | +0.63% since 11/20/24 | +4.66% since 11/20/24 |
| Low | 81.50 on 12/20/24 | 735.00 on 11/21/24 | 142.75 on 12/20/24 | 96.95 on 11/21/24 | 166.92 on 11/21/24 |
| High | 112.52 on 12/11/24 | 846.46 on 12/04/24 | 157.12 on 11/22/24 | 105.07 on 12/09/24 | 184.24 on 11/27/24 |
| 3-Month | |||||
| %Chg | -33.34% since 09/20/24 | -16.68% since 09/20/24 | -11.99% since 09/20/24 | -16.32% since 09/20/24 | -9.25% since 09/20/24 |
| Low | 81.50 on 12/20/24 | 711.40 on 11/18/24 | 142.75 on 12/20/24 | 94.48 on 11/15/24 | 163.81 on 11/19/24 |
| High | 127.61 on 09/25/24 | 939.30 on 09/25/24 | 166.75 on 10/15/24 | 118.16 on 09/23/24 | 207.32 on 10/31/24 |
| 6-Month | |||||
| %Chg | -39.71% since 06/20/24 | -13.34% since 06/20/24 | -2.24% since 06/20/24 | -24.38% since 06/20/24 | +2.00% since 06/20/24 |
| Low | 81.50 on 12/20/24 | 711.40 on 11/18/24 | 142.75 on 12/20/24 | 94.48 on 11/15/24 | 163.52 on 07/03/24 |
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | 134.63 on 06/25/24 | 207.32 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 381,440,256 | 728,846,848 | 347,829,312 | 248,030,720 | 310,274,432 |
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | 2,529,635 | 1,767,140 |
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | 60,115,000,000 | 54,318,000,000 |
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | 365,000,000 | 4,863,000,000 |
| Last Quarter Sales | 10,511,240,000 | 11,439,100,000 | 22,471,000,000 | 16,657,000,000 | 14,460,000,000 |
| Last Quarter Net Income | 4,024,170,000 | 970,300,000 | 2,694,000,000 | 3,157,000,000 | 1,561,000,000 |
| 60-Month Beta | 0.40 | 0.41 | 0.51 | 0.39 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.90 on 11/06/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | 1.57 on 10/31/24 | 3.00 on 10/30/24 |
| Latest Earnings Date | 01/29/25 | 02/04/25 | 01/22/25 | 02/04/25 | 02/07/25 |
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 11/15/24 | 1.240 on 11/26/24 | 0.810 on 12/16/24 | 1.550 on 10/15/24 |
| Next Ex-Dividends Date | 08/16/24 | 02/14/25 | 11/26/24 | 12/16/24 | 01/15/25 |
| Ratios | |||||
| Price/Earnings ttm | 33.48 | 74.49 | 14.02 | 16.73 | 15.96 |